News
September 3, 2013

Alabama Court Revisits ‘Innovator Liability’

The Alabama Supreme Court is scheduled to hear an appeal that could have huge implications for drug makers, reports Legal Newsline.  Before the court is the issue of ‘innovator liability,’ the legal theory that brand-name drug makers can be held liable for generic versions of their drugs.

In January, the court ruled that a plaintiff who took the generic version of Wyeth’s heartburn drug Reglan can sue Pfizer (which acquired Wyeth in 2009).  A Wall Street Journal editorial explains the drawbacks of the innovator liability theory:

The court’s judgment contradicts decades of Alabama tort and product liability precedent. In his dissent, Justice Glenn Mourdock wrote that the “bedrock principles” of tort law require that the law must create a climate that encourages innovation within a system of risk and reward. He added that the notion that “parties are responsible for their own products, not those of others, are so organic to western economic and legal thought that they rarely find need of expression.”

stethoscope with books News New Faces Of Lawsuit Abuse Video: Louisiana Medical Professionals Highlight Problems with Trial Lawyer Advertising Class Action Litigation, Medical Liability Video ILR Briefly Live Event: COVID-19 State Liability Issues and Solutions Foreign Corrupt Practices Act (FCPA), Medical Liability, Securities Litigation Reform, Telephone Consumer Protection Act (TCPA) Wearing Mask News Plaintiffs' Lawyers Seething Over Push To Limit COVID-19 Related Medical Liability Medical Liability News Protecting Doctors And Nurses On The Front Lines Of This Pandemic From Lawsuits Medical Liability News In The News Today - April 17, 2020 Medical Liability
We Use Cookies to Make your Experience Better

What do we use cookies for?

We use cookies and similar technologies to recognize your repeat visits and preferences, as well as to measure the effectiveness of campaigns and analyze traffic. To learn more about cookies, including how to disable them, view our Cookie Policy. By clicking "I Accept" or "X" on this banner, or using our site, you consent to the use of cookies unless you have disabled them.